FilingReader Intelligence
Sunflower Pharmaceutical merges subsidiaries in restructuring move
July 25, 2025 at 01:21 PM UTC•By FilingReader AI
Sunflower Pharmaceutical Group approved the deregistration of wholly-owned subsidiary Heilongjiang Sunflower Pharmacy and will merge two other subsidiaries - Heilongjiang Sunflower Packaging Materials and Heilongjiang Sunflower Medicinal Material Base - into Heilongjiang Sunflower Pharmaceutical.
The restructuring aims to enhance resource integration and reduce costs without changing the company's operating scope or capital structure.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SZSE:002737•Shenzhen Stock Exchange
News Alerts
Get instant email alerts when Sunflower Pharmaceutical Group publishes news
Free account required • Unsubscribe anytime